- ·Watch LoQus23 Therapeutics: the Monday email on marks, rounds and moves
LoQus23 Therapeutics funding history
No funding rounds for LoQus23 Therapeutics are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
LoQus23 Therapeutics valuation
LoQus23 Therapeutics's last known valuation is $61.4 million. The figure stands until a priced round, a secondary trade or an institutional fund mark prices the stock again.
How LoQus23 Therapeutics's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For LoQus23 Therapeutics, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked about LoQus23 Therapeutics
- What is LoQus23 Therapeutics worth?
- LoQus23 Therapeutics's last known valuation is $61.4M.
- How much has LoQus23 Therapeutics raised?
- LoQus23 Therapeutics has raised $67.2M in total funding across its recorded rounds.